News|Articles|January 26, 2026
Subvisible Particulate Matter Testing
Author(s)Entegris
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5